# Stryker receives court approval to acquire Novadaq

The Ontario Superior Court of Justice has issued a final order approving Stryker Corporation's acquisition of all shares of NOVADAQ Technologies Inc. for US$11.75 per share in cash. The deal is expected to close in Q3 2017, pending regulatory approvals.

- Type: Acquisition
- Announced: 2017-08-09
- Where: Canada
- Status: announced
- Products: SPY fluorescence imaging technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Stryker](https://endata.com/companies/15355.md) (acquirer)
- [NOVADAQ Technologies Inc.](https://endata.com/companies/24980.md) (target)

## Sources

- [biospace.com](https://www.biospace.com/novadaq-receives-court-approval-for-arrangement-with-stryker), 2017-08-10: "The Arrangement remains subject to the receipt of regulatory approvals under the Canadian Competition Act and U.S. Hart-Scott-Rodino and the satisfaction of certain other closing conditions."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.